Hugo Mathers
Reporter
Hugo joined Capital Brief after five years in government roles across London and Sydney. He also previously worked in venture capital with Europe's first proptech VC fund Pi Labs and edtech startup Primo Toys, and has written for Time Out, Urban List and The Mandarin.
Contact Hugo via email.
The SGH boss is tilting his construction and energy assets to capitalise on the AI arms race, while hunting an alternative M&A splash as the chances of a BlueScope deal fade.
The ASX-listed video game company cost buyers of its non-fungible tokens upwards of $8m when it scrapped its latest project.
Chief executive Will Lopes says consolidation across the fragmented sports technology sector is creating fresh acquisition opportunities as his company pushes toward breakeven.
The fertility treatment provider, which has rejected takeover approaches from Soul Patts and Genesis Capital this year, is aiming to prevent a repeat of two high-profile embryo mix-ups.
The telco has just witnessed a two-day price swing seldom seen by an ASX 200 company. All shareholders say they can do is hold and hope.
The most influential AI research firm in Silicon Valley has quietly scrutinised Aussie neoclouds. For ASX investors, its findings will raise eyebrows.
Chief executive Sukhinder Singh Cassidy says Xero is focused on long-term value, but some shareholders are struggling to see an end to the turmoil.
Founder and former chair Andrew Abercrombie jumped from the board before his fellow shareholders had the chance to push him. But he might be playing a longer game.
Six months after DroneShield’s governance blow-up, ASIC has confirmed it is investigating the counter-drone manufacturer, as some investors ask what took so long.
The biotech giant delivered a hammer blow of a guidance downgrade on Monday morning. Shareholders wanted it three months ago.
Executives spent most of the conference denying, defending and deflecting. But the week’s most revealing moments came when they talked about their plans for humans in an AI world.
